Answers are grounded in this paper and cite their sources.
Background/Objectives: Halitosis is common in patients with dental implants, but the contributions of peri-implant disease and prosthesis design remain unclear. We compared volatile sulfur compound (VSC) profiles across peri-implant health, mucositis, and peri-implantitis and evaluated factors associated with halitosis. Methods: This cross-sectional study included 74 patients with implants in function for at least 12 months, classified according to the 2018 World Workshop definitions (26 health, 25 mucositis, and 23 peri-implantitis). Hydrogen sulfide, methyl mercaptan, and dimethyl sulfide were measured by portable gas chromatography alongside organoleptic scores, tongue coating, salivary flow, and the Halitosis Associated Life-quality Test. A prespecified multivariable regression was complemented by exploratory cross-validated diagnostic, decision-curve, and mediation analyses. Results: Median total VSC increased across health, mucositis, and peri-implantitis, driven primarily by methyl mercaptan. Halitosis prevalence also increased across groups. Cement retention and limited cleaning access were independently associated with higher VSC. An exploratory model combining log-transformed methyl mercaptan, tongue coating, and smoking showed good cross-validated discrimination, and peri-implant bleeding statistically accounted for part of the association between peri-implantitis and VSC, although the cross-sectional design precludes causal inference. Conclusions: Peri-implantitis is associated with a methyl mercaptan-dominant breath profile, and modifiable prosthetic factors are associated with malodour. Whether breath analysis adds to conventional clinical examination was not tested and requires prospective evaluation.
No takes yet. Share an insight, caveat, or question.
Bita et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: